{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-020021","form_type":"8-K","ticker":"MASS","cik":"0001555279","company_name":"908 Devices Inc.","filed_at":"2025-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.981424+00:00","generated_at":"2026-05-25T13:55:26.723335+00:00","sec_items":["1.01","2.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"908 Devices sells desktop bioprocessing PAT portfolio to Repligen for $70M cash","bullets":["Purchase price $70M in cash, subject to customary working capital adjustment and escrow for indemnification.","Products sold: MAVERICK, MAVEN, REBEL, ZipChip; 908 Devices retains handheld device business.","Company agrees to 5-year non-compete in bioprocessing PAT and 18-month employee non-solicit.","Transition services provided through Dec 2025; supply and IP license agreements also executed.","Disposition does not require stockholder approval as it is not substantially all assets; pro forma financials to follow."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-020021","json":"https://secwatch.observer/filing/0001104659-25-020021.json","markdown":"https://secwatch.observer/filing/0001104659-25-020021.md","text":"https://secwatch.observer/filing/0001104659-25-020021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1555279/000110465925020021/0001104659-25-020021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1555279/000110465925020021/tm258071d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T13:55:26.723335+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b3d2bd375b9a331878256965064ce94cf60afe14","claim":"908 Devices Inc. completed a disposition involving Repligen Corporation and Repligen GmbH for $70,000,000 (closed 2025-03-04).","evidence_excerpt":"US Purchaser and the German Purchaser. The purchase price payable by the Purchasers for the Transferred Equity Interests and Purchased Assets under the Purchase Agreement was $70,000,000, subject to customary adjustment for working capital as more fully set forth in the Purchase Agreement. A portion of the purchase price will be held in escrow for a period of time","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1555279/000110465925020021/0001104659-25-020021-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Repligen Corporation and Repligen GmbH"},{"label":"Consideration","value":"$70,000,000"},{"label":"Closing","value":"2025-03-04"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}